SCHEMBL17164064

SCHEMBL17164064

Cn1c(=O)[nH]c2c(=O)[nH]cnc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.51
ADORA2A P29274 8/20 0.50
PDE4A P27815 7/20 0.50
PDE4B Q07343 7/20 0.50
PDE4C Q08493 7/20 0.50
PDE4D Q08499 7/20 0.50
ADORA2B P29275 4/20 0.50
ADORA3 P0DMS8 2/20 0.50
ADORA1 P30542 2/20 0.50
PIK3CD O00329 1/20 0.50
ALPL P05186 1/20 0.50
TMIGD3 P0DMS9 1/20 0.50
CYP2C19 P33261 1/20 0.50
HIF1A Q16665 1/20 0.50
HPGD P15428 1/20 0.47
BLM P54132 1/20 0.47
PDE3A Q14432 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylxanthine SCHEMBL237146 0.85 ADORA2A (0.64) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL30753411 0.84 ADORA2A (0.62) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL9317914 0.84 ADORA2A (0.62) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL4020124 0.84 ADORA2A (0.62) ATAD2ADORA2APDE4APDE4BPDE4C
SCHEMBL18704230 0.77 ADORA2A (0.77) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL27054264 0.77 ADORA2A (0.43) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL2791774 0.76 ADORA2A (0.58) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL4018085 0.75 ADORA2A (0.52) ATAD2ADORA2APDE4APDE4BPDE4C
3-Methylxanthine SCHEMBL1892894 0.75 ADORA2B (0.77) ATAD2ADORA2APDE4APDE4BPDE4C
Theobromine SCHEMBL4024314 0.74 MAPK1 (0.75) ATAD2ADORA2APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220440-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-11-16 WO disclosed
WO-2023220428-A1 COMPOSITIONS FOR EDITING ASS1 TRANSCRIPTS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-11-16 WO disclosed
WO-2022099159-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2022-05-12 WO disclosed
WO-2017064068-A1 NEW TRPA1 ANTAGONISTS ALMIRALL, S.A. (ES) 2017-04-20 WO disclosed
WO-2017060488-A1 NEW TRPA1 ANTAGONISTS ALMIRALL, S.A. (ES) 2017-04-13 WO disclosed
WO-2015155306-A1 NEW TRPA1 ANTAGONISTS ALMIRALL, S.A. (ES) 2015-10-15 WO disclosed